Mathis, Chester A.

Characterizing the emergence of amyloid and tau burden in Down syndrome

Zammit, M. D., Betthauser, T. J., McVea, A. K., Laymon, C. M., Tudorascu, D. L., Johnson, S. C., Hartley, S. L., Converse, A. K., Minhas, D. S., Zaman, S. H., et al. (2024) · Alzheimer's & Dementia

Dementia and Cognitive Impairment ResearchAlzheimer's disease research and treatments

Cited by 60

Comparison of amyloid burden in individuals with Down syndrome versus autosomal dominant Alzheimer's disease: a cross-sectional study

Boerwinkle, A. H., Gordon, B. A., Wisch, J., Flores, S., Henson, R. L., Butt, O. H., McKay, N., Chen, C. D., Benzinger, T. L. S., Fagan, A. M., et al. (2023) · The Lancet Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 55

In vivo evidence for low striatal vesicular monoamine transporter 2 (VMAT2) availability in cocaine abusers

Narendran, R., Lopresti, B. J., Martinez, D., Mason, N. S., Himes, M., May, M. A., Daley, D. C., Price, J. C., Mathis, C. A., & Frankle, W. G. (2012) · American Journal of Psychiatry

Neurotransmitter Receptor Influence on BehaviorParkinson's Disease Mechanisms and Treatments

Cited by 53

Comparison of tau spread in people with Down syndrome versus autosomal-dominant Alzheimer's disease: a cross-sectional study

Wisch, J. K., McKay, N. S., Boerwinkle, A. H., Kennedy, J., Flores, S., Handen, B. L., Christian, B. T., Head, E., Mapstone, M., Rafii, M. S., et al. (2024) · The Lancet Neurology

Alzheimer's disease research and treatmentsDementia and Cognitive Impairment Research

Cited by 37

Autoradiographic localization of binding sites for 125I-DOI, a new psychotomimetic radioligand, in the rat brain

McKenna, D. J., Mathis, C. A., Shulgin, A. T., Sargent, T., & Saavedra, J. M. (1987) · European Journal of Pharmacology

Neurotransmitter Receptor Influence on BehaviorRadiopharmaceutical Chemistry and Applications

Cited by 33

Dopaminergic activity and altered reward modulation in anorexia nervosa-insight from multimodal imaging

Bailer, U. F., Price, J. C., Meltzer, C. C., Wagner, A., Mathis, C. A., Gamst, A., & Kaye, W. H. (2017) · International Journal of Eating Disorders

Eating Disorders and BehaviorsNeurotransmitter Receptor Influence on Behavior

Cited by 33

Timeline to symptomatic Alzheimer's disease in people with Down syndrome as assessed by amyloid-PET and tau-PET: a longitudinal cohort study

Schworer, E. K., Zammit, M. D., Wang, J., Handen, B. L., Betthauser, T., Laymon, C. M., Tudorascu, D. L., Cohen, A. D., Zaman, S. H., Ances, B. M., et al. (2024) · The Lancet Neurology

Dementia and Cognitive Impairment ResearchDown syndrome and intellectual disability research

Cited by 29

An open‐label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)‐(–)‐O‐desmethylvenlafaxine and racemic O‐desmethylvenlafaxine

Frankle, W. G., Robertson, B., Maier, G., Paris, J., Asmonga, D., May, M., Himes, M. L., Mason, N. S., Mathis, C. A., & Narendran, R. (2018) · Synapse

Neurotransmitter Receptor Influence on BehaviorTreatment of Major Depression

Cited by 6